A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer

Clinical trial NCT00510718 · COMPLETED

Trial details

NCT number: NCT00510718
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Hormone Refractory Prostate Cancer

Start date: 2007-07-23
Primary completion: 2008-12-08
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.